Related Experiment Video
Updated: Aug 25, 2026
Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
[Intralesional corticosteroid injection in the treatment of chalazion]
D Kaimbo Wa Kaimbo1, M C Nkidiaka
1Service d'Ophtalmologie, Cliniques Universitaires de Kinshasa, Université de Kinshasa, BP 16540, Kinshasa 1, République Démocratique du Congo. kaimbo@raga.net
Objective:
To evaluate the efficacy of intralesional corticosteroid injection in the treatment of chalazia in black African patients.
Methods:
In a prospective study conducted between February 1999 and February 2000, 25 black African patients with chalazion (25 eyes, 29 chalazia), ranging in age from 15 to 54 years (mean age +/- SD, 30.6+/-9 years), were treated with intralesional triamcinolone (injection of 0.075 - 0.5 ml triamcinolone acetate at a 5-mg/ml concentration).
Results:
Success was achieved in 18 (72%) of 25 patients [20 (74%) out of 27 eyes, 22 (76%) out of 29 chalazia)]. In 11 of 25 patients, two intralesional injections were necessary to obtain these results. Recurrence occurred in five eyes (five chalazia, 17%) after 5-6 weeks. During a mean +/- SD of 4.68 months (range, 3.5-12 months) of follow-up, no postinjection ocular complication occurred.
Conclusion:
Intralesional corticosteroid injection appears to be effective in managing chalazion in black African patients, as reported in previous studies in Caucasian patients. This treatment can be used when curettage is contraindicated.
